Learn more about the evidence piling up that cognitive problems can start earlier than we might expect.

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

In an age where the pursuit of eternal youth dominates wellness trends and biohacking headlines, a new study offers promising—but grounded—insights into one possible solution: vitamin D. A recent ...

Many are turning to weight-loss drugs, but doctors said they have their limitations and that the long-term side effects are ...

The following year, legislators in the Golden State approved another measure that, starting in 2028, will ban six food dyes — Blue 1, Blue 2, Green 3, Red 40, Yellow 5 and Yellow 6 — from being sold ...

Menopausal hormone treatment (MHT) might indirectly help with weight loss by improving sleep and redistributing abdominal fat ...

For many of us, the idea of eating dinner at 4 or 5 p.m. conjures up images of early-bird specials and retirees flocking to ...

Who wants to live forever? Lots of us do, it seems. Australians are searching for terms like “longevity” more than ever and social media is full of longevity advice. Living longer is high on the ...

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

Concurrent hypertension and type 2 diabetes significantly increase mortality risk, emphasizing the need for targeted health ...

Scientists discover unique insulin responses in each person, opening new paths for early diabetes detection and treatment.